Avidian Wealth Enterprises’s ProPhase Labs PRPH Stock Holding History

Avidian Wealth Enterprises’s Portfolio PRPH Stock Details PRPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-15,602	Closed	-$1.13M	–	420
2023 Q2	$1.13M	Hold	15,602	–	–	0.07%	162
2023 Q1	$1.19M	Hold	15,602	–	–	0.07%	178
2022 Q4	$1.5M	Hold	15,602	–	–	0.1%	138
2022 Q3	$1.76M	Buy	15,602 +909	+6%	+$106K	0.13%	110
2022 Q2	$1.86M	Buy	14,693 +659	+5%	+$57.9K	0.13%	117
2022 Q1	$982K	Buy	14,034 +2,059	+17%	+$143K	0.06%	199
2021 Q4	$859K	Buy	11,975 +1,455	+14%	+$90.5K	0.05%	210
2021 Q3	$547K	Buy	10,520 +5,024	+91%	+$299K	0.04%	202
2021 Q2	$341K	Buy	5,496 +4,449	+425%	+$250K	0.03%	289
2021 Q1	$77K	Buy	+1,047	New	+$100K	0.01%	362

Other funds holding PRPH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PCM

Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return

Avidian Wealth Enterprises's PRPH Position: Q3 2023 in Review

Avidian Wealth Enterprises sold out of ProPhase Labs (PRPH) in Q3 2023, closing a stake of 15,602 shares — an estimated $1.13M sold.

Avidian Wealth Enterprises first reported a position in PRPH in Q1 2021 and held it in 10 quarters. The position peaked at $1.86M in Q2 2022. 35 funds tracked by Wall St. Rank hold PRPH as of Q3 2023.

Avidian Wealth Enterprises reported no remaining ProPhase Labs position as of Q3 2023 after selling out during the quarter.
Avidian Wealth Enterprises sold 15,602 ProPhase Labs shares in Q3 2023, an estimated $1.13M.
Avidian Wealth Enterprises first reported a position in ProPhase Labs in Q1 2021 and held it in 10 quarters.
Avidian Wealth Enterprises's ProPhase Labs position peaked at $1.86M in Q2 2022.
35 funds tracked by Wall St. Rank held ProPhase Labs as of Q3 2023.

Based on Avidian Wealth Enterprises's 13F filing for Q3 2023, filed 13 Oct 2023.